|
22 Aug 2007 |
SemBioSys Updates Apo AI Development Program
|
|
22 Aug 2007 |
Artisan Pharma, Inc. launches Phase 2b trial of ART-123 for the treatment of DIC in sepsis
|
|
21 Aug 2007 |
Solvay Pharmaceuticals, Inc. Receives Approvable Letter from FDA with Respect to New Drug Application for CREON(R)
|
|
21 Aug 2007 |
Liraglutide improves glucose control and lowers body weight in two phase 3 studies comprising more than 2,000 patients
|
|
21 Aug 2007 |
Wyeth Receives Approval from European Medicines Agency for New BeneFIX Features
|
|
21 Aug 2007 |
Pharming reports positive results in European placebo-controlled trial Of Rhucin(R) in hereditary angioedema
|
|
17 Aug 2007 |
Jerini Receives EMEA Filing Acceptance of its Marketing Application for Icatibant in the Treatment of Hereditary Angioedema
|
|
15 Aug 2007 |
Oramed Pharmaceuticals Successfully Completes Phase 1A Trials
|
|
15 Aug 2007 |
Altus Pharmaceuticals’ ALTU-237 Enters Phase I Clinical Trial for the Treatment of Hyperoxalurias and the Potential Prevention of Kidney Stone Formation
|
|
14 Aug 2007 |
BioMarin partner AnGes MG, Inc. submits BLA to Japanese Ministry of Health
|
|
14 Aug 2007 |
BioDiem completes treatment in phase I/II study of eye drug BDM-E: Results due November 07
|
|
11 Aug 2007 |
Unigene in-licenses potential therapies for inflammation and cardiovascular disease from University of London
|
|
10 Aug 2007 |
Protalix BioTherapeutics signs agreement to license acetylcholinestrase development technology
|
|
09 Aug 2007 |
Positive Phase 1b transdermal insulin clincial trial results
|
|
09 Aug 2007 |
The Medicines Company submits Angiomax(R) (Bivalirudin) sNDA to expand label to include ACUITY data
|
|
09 Aug 2007 |
Nutra Pharma Announces Positive Results of ReceptoPharm Pain Study
|
|
09 Aug 2007 |
Tercica Receives Marketing Approval for Increlex in the European Union
|
|
08 Aug 2007 |
MicroDose announces positive results from the QDose inhaled insulin glucose clamp study
|
|
07 Aug 2007 |
First patient enrolled into ATryn (R) Phase II study in DIC indication
|
|
04 Aug 2007 |
Patients treated with Betaferon(R) after first MS attack experienced significant delay in disability progession
|
|
03 Aug 2007 |
Unigene Initiates Oral Calcitonin Clinical Study in Humans
|
|
02 Aug 2007 |
Lev Pharmaceuticals Submits Biologics License Application for Cinryze(TM)
|
|
01 Aug 2007 |
Laureate Pharma Announces Agreement with Enobia Pharma, Inc.
|
|
31 Jul 2007 |
Cadence Pharmaceuticals announces agreement with fda on increased enrolment in Phase III clinical trial of Omigard (TM)
|
|
28 Jul 2007 |
OSI Pharmaceuticals Announces Agreement to Divest Anti-Platelet Derived Growth Factor (PDGF) Program
|
